Species: SARS Coronavirus 2
Form: Lyophilized powder
Buffer (with preservative): Reconstitute with distilled water to 0.4 mg/ml. Lyophilized from , no Preservative.
Concentration: (Please refer to the vial label for the specific concentration.)
Region Sequence: SARS-CoV-2 Spike of QHD43416.1 (1-1213 a.a, extracellular domain) with KP.3.1.1 mutation (T19I, R21T, L24del, P25del, P26del, A27S, S31del, S50L, H69del, V70del, V127F, G142D, Y144del, F157S, R158G, N211del, L212I, V213G, L216F, H245N, A264D, I332V, G339H, K356T, S371F, S373P, S375F, T376A, R403K, D405N, R408S, K417N, N440K, V445H, G446S, N450D, L452W, L455S, F456L, N460K, S477N, T478K, N481K, V483del, E484K, F486P, Q493E, Q498R, N501Y, Y505H, E554K, A570V, D614G, P621S, H655Y, N679K, P681R, N764K, D796Y, S939F, Q954H, N969K, V1104L, P1143L), S1-S2 cleavage site mutations (682-685GSAS), 6 stabilizing (HexaPro) mutations (F817P, A892P, A899P, A942P, K986P,V987P), and T4 trimerization domain as well as a C-terminal His tag.
ExpressionSystem: HEK293 cells
Conjugation: Unconjugated
English
Deutsch
